AG2R LA Mondiale Gestion D Actifs Invests $2.80 Million in HCA Healthcare, Inc. $HCA

Key Points

• AG2R LA Mondiale Gestion D Actifs acquired a new stake in HCA Healthcare, purchasing 7,347 shares worth approximately $2.8 million in the first quarter of the year.
• HCA Healthcare reported a quarterly earnings per share of $6.84, exceeding analyst expectations, with revenue of $18.61 billion, a 6.4% year-over-year increase.
• The company announced a quarterly dividend of $0.72, resulting in an annual dividend yield of 0.7%, with a payout ratio of 12.11%.

AG2R LA Mondiale Gestion D Actifs acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 7,347 shares of the company's stock, valued at approximately $2,802,000.

A number of other institutional investors have also recently bought and sold shares of the business. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare during the 1st quarter worth $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare during the 1st quarter worth $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare during the 1st quarter worth $27,000. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare during the 1st quarter worth $28,000. Finally, Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares during the period. Institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on HCA shares. Morgan Stanley cut their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Bank of America raised their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research note on Wednesday, September 10th. Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Finally, Wells Fargo & Company lowered their price target on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $407.75.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Trading Up 0.4%

HCA Healthcare stock traded up $1.40 during trading hours on Thursday, reaching $400.79. The company had a trading volume of 448,822 shares, compared to its average volume of 1,519,687. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company has a 50-day moving average price of $384.23 and a 200 day moving average price of $364.54. The firm has a market cap of $93.78 billion, a price-to-earnings ratio of 16.88, a P/E/G ratio of 1.26 and a beta of 1.41. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.